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Abstract
To understand how integration of multiple data types can help decipher cellular responses at the systems level, we analyzed
the mitogenic response of human mammary epithelial cells to epidermal growth factor (EGF) using whole genome
microarrays, mass spectrometry-based proteomics and large-scale western blots with over 1000 antibodies. A time course
analysis revealed significant differences in the expression of 3172 genes and 596 proteins, including protein
phosphorylation changes measured by western blot. Integration of these disparate data types showed that each
contributed qualitatively different components to the observed cell response to EGF and that varying degrees of
concordance in gene expression and protein abundance measurements could be linked to specific biological processes.
Networks inferred from individual data types were relatively limited, whereas networks derived from the integrated data
recapitulated the known major cellular responses to EGF and exhibited more highly connected signaling nodes than
networks derived from any individual dataset. While cell cycle regulatory pathways were altered as anticipated, we found
the most robust response to mitogenic concentrations of EGF was induction of matrix metalloprotease cascades,
highlighting the importance of the EGFR system as a regulator of the extracellular environment. These results demonstrate
the value of integrating multiple levels of biological information to more accurately reconstruct networks of cellular
response.
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Introduction
Systems biology is an approach to develop comprehensive and
ultimately predictive models of how components of a biological
system give rise to its observed behavior [1,2]. Because of the
complexity of biological organisms, however, this approach has
proven most successful when applied to relatively small-scale
systems [3]. Applications to more significant and complex
problems have recently been enabled by technical advances in
molecular biology and genome sequencing, which generate high-
dimensional data with the appropriate throughput and sensitivity.
Genome-wide mRNA expression profiling using cDNA and
oligonucleotide microarrays or serial analysis of gene expression
have proven valuable in identifying mRNA expression changes
associated with disease, metabolic states, development and
exposure to drugs and environmental agents [4,5,6,7]. More
recent advances in mass spectrometry (MS)-based proteomics
using stable isotope labeling have made quantitative protein
profiling, including measures of post-translational protein modi-
fication, feasible at a global scale [8,9,10]. A variety of other
technologies capable of providing high-dimensional biological
response data has also emerged, including multiplexed protein
microarrays, flow cytometry, and two-hybrid systems for mapping
protein interactions [11,12,13,14]. Datasets derived from these
technologies can potentially provide a foundation for building
quantitative models of biological systems but only if they can be
integrated into a coherent relational network of cellular response.
Most current high-throughput technologies only provide data
for a single molecule type, and the underlying regulatory structure
of the cell must be inferred from their qualitative or quantitative
relationships. Data describing only a single level of biological
regulation is unlikely to fully explain the behavior of complex
biological systems. Thus, there is a need for integrating data from
multiple sources representing different hierarchical levels of
regulation to reconstruct more complete cellular networks. For
example, studies comparing mRNA and protein expression
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predictors of protein abundance [15,16]. Mathematical modeling
of these processes suggests that understanding the regulation of
simple cellular networks requires data describing the dynamics of
both mRNA and protein expression levels [17]. Estimating steady-
state mRNA and protein changes from a single time point,
however, can be misleading because of the time needed for protein
synthesis and degradation. To our knowledge, temporal-based
analyses of correlations between global protein and gene
expression patterns in human cells have yet to be reported.
The necessity for integrated data analysis across ‘omics
platforms is further driven by the desire to identify fundamental
properties of biological networks, such as redundancy, modularity,
robustness, and feedback control [1,18,19]. Such properties
provide the underlying structure of signaling networks, yet they
are difficult to specify using a single type of analytical
measurement. While the need for data integration is clearly
recognized, in practice there are few reported examples that
quantify the benefits gained by this approach, particularly for
mammalian systems. Notably, little effort has been made to
systematically evaluate the degree of information overlap provided
by different types of ‘omics data and how they can distinctly
inform network and pathway analyses. This is despite the fact that
all high-throughput technologies have varying sampling efficien-
cies and systematic biases and limitations that give rise to different
false positive and false negative rates. Consequently, it is unclear
whether the cell response pathways revealed by integrating
microarray and proteomic data will be more informative than
those inferred by global mRNA microarray data alone.
To explore the practicality of integrating different types of high-
throughput data to understand complex cellular functions, we
have conducted a multidimensional analysis of the temporal
response of human mammary epithelial cells (HMEC) to
epidermal growth factor receptor (EGFR) activation. EGFR
signaling plays an important role in regulating proliferation and
motility in many epithelial cells and can integrate signals from
diverse pathways through receptor crosstalk [20]. Both the
proliferation and motility of HMEC require EGFR activation
[21,22]. Conveniently, HMEC can be arrested in the cell cycle by
removing EGF in the culture medium, and subsequently induced
to synchronously reenter the cell cycle by re-addition of EGF. This
allows examination of the dynamics of the mitogenic response
without using inhibitors or other non-physiological treatments.
In this study, we examined time-dependent changes in gene and
protein expression patterns following EGF treatment of synchro-
nized HMEC to determine how data from each platform
qualitatively contributed to pathway and network analysis. While
the cell processes identified by each data type varied significantly,
integration of the multiple datasets recapitulated most of the
known mitogenic pathways mediated through EGFR. Further-
more, networks derived from the combined datasets exhibited
more highly connected signaling nodes with an appropriate
hierarchical structure than networks derived from any individual
dataset. This study demonstrates that integration of multiple data
types provides complementary, not redundant, information
necessary to reconstruct complex cellular response networks.
Results
Changes in Gene and Protein Expression during the
HMEC Mitogenic Response
To determine the degree to which changes in common cell
regulatory networks are detected by different high-content data
technologies, we analyzed the temporal response of cells to
activation of EGFR using whole genome microarrays, high
throughput Western blots (Powerblot
TM), and mass spectrome-
try-based proteomics. The experimental strategy (Fig. 1A) used
takes advantage of the inherent dependence of HMEC on EGFR
autocrine signaling for normal cell proliferation. Previous studies
have shown that removal of EGFR ligands from culture medium
or blocking EGFR activation causes HMEC to reversibly arrest in
G0/G1 of the cell cycle [22]. We used this approach to induce a
synchronized EGFR signaling response and facilitate network
analysis from time-course data. At different times following EGF
addition, we collected sufficient sample for parallel microarray,
Western blot, and MS-based proteomics analysis (Fig. 1A).
Monitoring the G1-S-G2/M transitions by flow cytometry
(Fig. 1B) also yielded a temporal benchmark for the EGF-induced
signaling responses. Removal of serum and growth factors caused
.95% of the cells to arrest in G0/G1 phase. Subsequent addition
of EGF induced a G1-S transition between 13–14 hr, followed by
entry into G2/M between 18–22 hr (Fig. 1B).
A complete listing of the significant RNA and protein changes
identified by each platform is provided in the supplementary
information (Table S1). Among 38,108 probesets on the micro-
array platform, 3172 RNA expression profiles were found to
significantly vary from the control (0 hr) based on analysis of
variance, false discovery rate (FDR) calculation (5%) and a 1.5-fold
change threshold (relative to control) in at least one of the time
points (Fig. 2). Since our overall goal was to evaluate the impact of
data integration in assessing global cell responses, these criteria
were set to maximize the overlap of potential gene changes
between datasets.
Categorically, RNAs that changed represented a wide variety of
cell processes including immediate early genes, cell cycle
regulatory genes, anti-apoptotic genes, matrix remodeling and
proteolytic genes. The most highly-induced genes identified across
all time points examined were extracellular proteases, including
interstitial collagenase (MMP1, 24-fold induction), and stromelysin
2 (MMP10, 8-fold induction). We also observed early gene
induction patterns, including activating transcription factor 3
(ATF3) and prostaglandin-endoperoxide synthase 2 (PTGS2),
which were transiently up-regulated at 1 hr and returned to basal
levels by 4 hr. A dramatic change in gene expression at the 24 hr
time point was observed, reflecting the shift in cell population to
G2/M measured by flow cytometry.
To measure changes in protein level by MS, we used the
accurate mass and time (AMT) tag strategy [23]. In this approach,
peptides (AMT tags) were identified using liquid chromatography-
Fourier transform ion cyclotron resonance mass spectrometry (LC-
FTICR) analysis, based on both accurate mass measurements and
chromatographic elution times in reference to a mass tag database
of proteins expressed in HMEC [9,24,25,26]. The advantages of
this approach have been previously described [23] and include
increased sample throughput and dynamic range compared to
typical LC-MS/MS analyses, as well as providing a measure of
protein abundance. Using conservative criteria previously de-
scribed [9], 2193 proteins were identified in the EGF-treated
HMEC samples by LC-FTICR. A stable isotope labeling
approach that employs quantitative exchange of either
16Oo r
18O at the site of trypsin digestion was also used to estimate protein
abundances [9]. This approach permitted ratiometric analysis of
the LC-FTICR results similar to that commonly used for RNA
microarray data. Based on the calculated ion intensity ratios of
treated to control (
18O/
16O), and using a significance threshold of
1.5-fold change, 511 proteins (with $2 peptide identifications
each) were found to change in abundance in response to EGFR
activation (Fig. 2). The 1.5-fold significance level was chosen to
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on our previous analyses that demonstrate a high reproducibility
for the
18O/
16O labeling method [9] and is consistent with
analogous global proteomic studies [27].
The antibody-based proteomic analysis by Western blots from
triplicate analyses indicated that 83 out of 612 detected proteins
showed a $1.5 fold difference in abundance in response to EGF
treatment (at any time point) compared to 0 hr controls (Fig. 2).
These analyses also included antibodies that selectively recognize
phosphorylated proteins, providing an additional dimension of
data. Among the total proteins identified by Western analysis, 20
were phosphorylated, and 9 of these significantly changed
phosphorylation levels after adding EGF. These included rapid
increases in phosphorylation of SRC, MAPK1 (ERK2), and
STAT3 consistent with the ability of EGFR stimulation to induce
phosphorylation of these signaling molecules [10]. The temporal
pattern of ERK2 phosphorylation during the HMEC mitogenic
response was biphasic, similar to results from our previous studies
of ERK2 activation patterns regulated by EGFR transactivation
[20]. Additional proteins that were phosphorylated in response to
EGFR activation included catenin delta 1(CTNND1), mitogen-
activated protein kinase 14 (MAPK14), and c-AMP-dependent
protein kinase type 2 (PRKAR2B).
Data Integration
To estimate the degree of concordance between RNA and
protein expression changes, the subset of proteins observed to
change by LC-FTICR analysis (511) was merged with the
corresponding gene expression values measured on the microarray
platform. By cross-referencing platform-specific identifiers to
common gene symbols [28], 446 RNA/protein pairs could be
reliably cross-indexed and analyzed. We first used k-means cluster
analysis (Fig. 3) to assess the heterogeneity between measured
RNA and protein expression profiles, which may represent
differential mechanisms of regulation. Some clusters of RNA/
protein pairs show a classical pattern of regulation, where RNA
changes preceded or coincided with a corresponding change in
protein abundance (Fig. 3, clusters A,B). Other clusters show
complex patterns that imply feedback processes between protein
half-life and compensatory RNA induction. For example, the
Figure 1. Experimental design and characterization of cell cycle transition with EGF treatment. A) Experiments were scaled to provide
sufficient sample for parallel analyses by gene microarray, global proteomics and Western blot technologies. B) Flow cytometry results showing the
time course for transitions between G1/S and G2/M phases during EGF-induced mitosis.
doi:10.1371/journal.pone.0034515.g001
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early times following EGFR activation (Fig. 3, cluster C). The
decline in protein abundance for this cluster was followed by an
apparent increase in RNA synthesis, which was then followed by
an increase in protein abundance to higher levels by 24 hr. In
other clusters, the concordance between RNA and protein
expression changes was not apparent, suggesting that steady-state
changes in RNA and protein abundance in those species were
regulated independently.
Because multiple time points were measured in this study,
multivariate correlation analysis was also used to assess the global
correlation between RNA expression and protein abundance
changes over time. Canonical correlation analysis was used to
identify a linear combination of time points that maximizes the
correlation between RNA and protein expression profiles [29].
Since RNA and protein expression may proceed at different rates,
this approach facilitated identifying multiple, non-obvious corre-
lations between the two expression profiles. For this analysis, only
RNA/protein pairs with complete data across all time points were
used, resulting in 199 pairs. We evaluated the significance of the
observed canonical correlations by randomizing the protein
identifiers while maintaining the data for individual time profiles
intact and canonical correlations for each of 1000 permutations
were calculated. The first observed canonical correlation exceeds
all corresponding permuted (randomized) values, and the second
canonical correlation exceeds 99% of permuted values, so both are
considered statistically significant (Fig. 4A). A scatter plot of first
canonical variable between RNA and protein expression for the
199 genes shows a correlation coefficient of 0.44 (Fig. 4B). This
result is generally consistent with previous studies that have
examined correlations between gene and protein abundance at
single time points [27,30,31,32]. These data imply that even when
time course data is compared, a significant fraction of the protein
abundance changes were not tightly coupled with a corresponding
temporal change in RNA expression, providing strong evidence
for substantial post-transcriptional regulation of protein expression
following growth factor stimulation.
The overall smoothed shapes of the temporal RNA and protein
expression patterns derived by regression were also compared and
ranked using a test F-statistic in order to identify some of the most
concordant and discordant RNA/protein pairs (Figure S1). An
important question is whether there is any relationship between
the degree of concordance of RNA and protein profiles and the
general function of the protein(s). While this question is difficult to
address globally, it can be approached by determining whether
concordant RNA/protein pairs are found to be more frequently
associated with specific gene ontology (GO) biological process
terms. To address this, we first evaluated the overall coherence for
the RNA and protein expression profiles separately within each
biological process category using a logistic regression model.
Table 1 shows that for only one biological process, ‘‘transcription’’,
the gene expression data for all 23 genes within the process were
significantly fit to a single logistic regression model. However, the
LC-FTICR data show good fit for protein abundance profiles
within the ‘‘primary metabolism’’, ‘‘protein metabolism’’ and
‘‘stress response’’ processes. Next, we determined the degree to
which particular biological processes showed positive concordance
using a Wilcoxon rank sum test between concordance score (F-
statistic) and category membership. For these comparisons, the
frequency with which each functional category was represented in
the overall dataset was used to normalize the results.
RNA/protein pairs in the biological process ‘‘protein metabo-
lism’’ displayed more positive concordance than predicted by
chance. Examples include proteins involved in protein processing
and translational regulation of protein synthesis, such as eukaryotic
translation initiation factor 4E (EIF4E) and ribosomal binding
protein 1 homolog (RRBP1). In contrast, RNA/protein pairs in
the ‘‘primary metabolism’’ category showed more anti-correlated
Figure 2. Hierarchical cluster analyses showing temporal changes in expression ratios for significant RNA and protein changes. The
scale bar indicates the log10 expression ratio compared to 0 hr controls. Values in gray indicate the protein/phosphorylated protein was not detected
at that time point.
doi:10.1371/journal.pone.0034515.g002
Integrated Network Analysis of EGF Signaling
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e34515Figure 3. K-means cluster analysis comparison of microarray and LC-FTICR expression ratio data. The left panel shows the overall results
for 446 RNA/protein pairs expressed as the log10 ratio over 0 hr control samples. Panels A–C highlight 3 different clusters that show different overall
temporal patterns between the RNA and protein data.
doi:10.1371/journal.pone.0034515.g003
Figure 4. Canonical correlation analysis of RNA and protein temporal expression profiles. A) Ranked canonical correlations between RNA
expression and protein expression, compared with random permutations. Each gray line shows the computed canonical correlations for a single
random permutation. The first observed canonical correlation exceeds all corresponding permuted values, and the second canonical correlation
exceeds 99% of permuted values; both are considered statistically significant. B) Scatter plot of first canonical variable between RNA and protein
expression for 199 gene/protein pairs with a correlation coefficient of 0.44.
doi:10.1371/journal.pone.0034515.g004
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proteins involved in fatty acid and carbohydrate metabolism, such
as acetyl-coenzyme A acetyltransferase 1 (ACAT1) and pyruvate
dehydrogenase alpha 1 (PDHA1). RNA/protein pairs whose
annotation involved ‘‘signal transduction’’, ‘‘stress response’’, or
‘‘intracellular transport’’ processes, however, showed no statisti-
cally significant trend toward either concordant or discordant
abundance changes based on the Wilcoxon rank sum test. These
results provide strong support for previous assertions that the
concordance between RNA and protein expression varies between
specific functional classes of proteins [33,34]. However our results
are in contrast to those obtained in yeast, where genes associated
with protein synthesis tend to show discordance between mRNA
and protein abundance [27].
Pathway and Network Analysis
To determine the extent to which we could reconstruct the
known EGFR regulatory networks from our datasets, we used the
MetaCore software suite (GeneGo, St. Joseph, MI), which uses a
curated, literature-based database of interaction and regulatory
relationships to generate network maps from sets of differentially
expressed genes or proteins. This approach was necessary because
the limited number of conditions represented by the proteomic
and microarray data in this study is insufficient to computationally
infer connectivity between gene expression and protein expression
nodes. We first evaluated whether similar biological processes
regulated by EGFR activation are captured by each high-
dimensional data platform by conducting gene set enrichment
analysis on each dataset separately. The results (summarized
across all time points) demonstrate that each data type emphasizes
a specific pattern of cellular processes (Fig. 5A). The most
significant biological processes in the microarray data include ‘‘cell
cycle’’, ‘‘mitosis’’ and ‘‘protein folding’’, which were poorly
represented by both proteomic datasets. The biological process
most significant from the LC-FTICR data was ‘‘protein
biosynthesis’’, which in turn was poorly represented by the
microarray and antibody-based proteomic results. The most
significant processes from the antibody-based analysis were ‘‘signal
transduction’’ and ‘‘protein phosphorylation’’, and neither process
was highly represented by either microarray or LC-FTICR
analysis. Cellular processes associated with cell adhesion and cell
motility were similarly represented by data across all measurement
platforms.
To determine whether the pathway analyses of our integrated
datasets made biological sense given our current understanding of
EGFR signaling, we also analyzed how the major cell processes
evolved over time. For these analyses, the major cell processes
represented by the combined data were statistically ranked
according to early (0–4 hr), intermediate (8–13 hr) and late (18–
24 hr) time domains after EGFR activation (Fig. 5B). Significantly,
the combined results recapitulate many of the expected cell
processes associated with mitogenic and motility responses
regulated by EGFR activation in these cells [20,21,22]. For
example, ‘‘cytoskeletal organization’’ and ‘‘protein folding’’ (which
includes protein chaperones involved in signal transduction)
processes are highly represented soon after EGFR stimulation.
Interestingly, anti-apoptotic pathways are significantly increased at
times preceding entry into S-phase. Further, the most highly
represented biological process in the 18–24 hr time domain is
‘‘mitosis’’, consistent with the flow cytometry analysis results.
The results in Fig. 5 clearly demonstrate that different types of
high-dimensional data provide qualitatively different views of the
cell processes regulated by EGFR. However, to determine whether
combined datasets can provide a more integrated understanding of
EGFR signaling networks, we needed to first analyze the network
structures obtained from each dataset individually. We evaluated
how the connectivity of the inferred signaling networks differed
among the individual datasets, and then how this changed when
the datasets were merged. This overall connectivity reflects the
ability of the data to accurately and comprehensively reconstruct
the cell response networks. For this analysis, the individual and
combined results from the early time domain (0–4 hr) data were
used to infer regulatory networks based upon direct regulatory
interactions between ‘‘nodes’’ (regulatory molecules) and ‘‘edges’’
(interactions) within the MetaCore database, however similar
results were obtained for the middle and late time domains.
An example of the general network structure and connectivity of
the major networks derived from early time domain data is shown
in Fig. 6. The results in Table 2 summarize the network statistics
obtained from this analysis. The largest network derived from the
microarray data alone was a cluster of 50 nodes, out of 311 nodes
with identified edges. The LC-FTICR data produced a smaller
cluster of 19 nodes out of a total of 185 nodes with edges,
consistent with the smaller number of overall changes identified by
LC-FTICR as compared to microarray. The most highly linked
nodes (hubs) in the microarray data were transcription factors,
including FOS (15 edges) and EGR1 (10 edges). In contrast, the
Table 1. Summary of statistical analysis of concordance patterns among GO biological process categories.









Primary metabolism 22 XX 2
Protein metabolism 47 XX +
Signal transduction 36
Stress response 17 XX
Transcription 23 X
Unclassified 17
LR: logistic regression; X: p,0.05; XX: p,0.01.
+: more concordance than expected by chance.
2: less concordance than expected by chance.
doi:10.1371/journal.pone.0034515.t001
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proteins, including EGFR (7 edges) and alpha-6, beta-1 integrin (7
edges) as the hub nodes. Thus, in the absence of the proteomics
data, microarray data alone did not call out EGFR as a signaling
node in the mitogenic response to EGF. Combining these two
datasets generated a large cluster of 142 nodes, with the
connectivity of the highly linked EGFR node from the LC-FTICR
data increasing dramatically to 16 edges. When the microarray,
LC-FTICR and PowerBlot data were all combined, the largest
network cluster grew only modestly to 169 nodes. However, the
connectivity of the highly linked nodes increased to 21 edges for
EGFR and 28 edges for FOS (Table 2).
One of the most highly linked nodes in the largest network
cluster was SRC (25 edges), which emerged from the protein
phosphorylation data obtained from the antibody analysis (Fig. 6).
Other well-connected hub nodes represented by phosphorylation
data alone included STAT3 and ERK2. Merging the microarray,
LC-FTICR and PowerBlot data also increased the overall
connectivity of the networks, with 34% of the nodes included in
the largest network cluster compared to only 16% with microarray
alone (Table 2). In addition, the degree of the largest network
clusters increased to an average of 3.4 edges per node.
Each data type also contributed to different types of edges in the
overall inferred network. For example, from the microarray data
alone, 63% of the edges were inferred to be transcriptional
regulatory relationships whereas only 17% were inferred to be
direct protein interaction events. In contrast, 60% of the edges
from the LC-FTICR data were inferred to represent protein
interaction events and only 4% to represent direct transcriptional
regulation. These findings are not unanticipated, but they provide
an indicator of the added value of each data type in the
reconstruction of cell response networks.
Since the primary goal of our study was to quantify the benefits
of data integration across different measurement platforms for
network and pathway analysis, the EGFR system was a valuable
system due to the extensive knowledge of signaling networks it is
coupled to. However, a surprising observation from our combined
results was that the most robust response to mitogenic concentra-
tions of EGF was not cell cycle regulation, but induction of matrix
metalloproteinase cascades. Indeed, RNA levels for interstitial
Figure 5. Major cell processes represented by each high-dimensional dataset. The biological processes represented by each data type
across all time points (Panel A) were determined by gene set enrichment and significance values are p-values calculated within the MetaCore
software. Only the cell processes showing the highest significance values are shown. The results in panel B show the major cell processes for all
combined data, separated based on early (0–4 hr), intermediate (8–13 hr) or late (18–24 hr) time points after EGFR activation.
doi:10.1371/journal.pone.0034515.g005
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largest changes observed in the study, increasing 24- and 8-fold,
respectively. To validate these high-throughput measurements,
additional experiments were conducted using orthogonal tech-
niques to measure the secretion of MMP1 and MMP10 protein.
ELISA analysis of conditioned medium collected from HMEC
during mitogenic stimulation confirmed that high levels of both
MMP1 and MMP10 protein are secreted in a manner that is
dependent on EGFR kinase activity (Figure S2).
Discussion
The concept that integration of data derived from multiple
levels of biological regulation will improve our understanding of
signaling networks is generally accepted, yet is rarely practiced in
biological research. To our knowledge, this study is the first
systematic analysis of the practical benefits of merging heteroge-
neous temporal data for purposes of network and pathway
interrogation in human cells. We focused on the EGFR pathway
because it plays an important role in epithelial cell regulation and
cancer biology, and there is mounting evidence that EGFR
transactivation is coupled to wide variety of external stimuli
[20,35]. The extensive literature on this pathway also provided a
means for validating our pathway analysis results. We demonstrate
that data from different types of high-dimensional platforms
independently provided qualitatively different views of EGFR-
induced cell processes and pathways. However, when data
representing RNA regulation, protein abundance and protein
phosphorylation were combined, the results recapitulate the major
processes and signaling networks known to be regulated by EGFR
in this cell type.
An important reason for integrated data analysis is that RNA
abundance changes are not always a good predictor of protein
abundance changes, especially over a time scale of several hours.
The canonical correlation analysis we describe here has advan-
tages over simple correlation analysis, since it can conceptually
capture RNA and protein expression profiles that are ‘‘concor-
dant’’ yet out of sync due to temporal delays. The canonical
correlation of 0.44 found in this study is greater than correlations
previously reported in which the slopes of RNA and protein
temporal profiles were used for comparison [33]. However, even
when temporal shifts between RNA and protein expression
profiles were considered for the EGF-stimulated state through
statistical modeling of time course data, we found that no more
than half of the protein abundance changes measured by LC-
FTICR were accompanied by corresponding RNA changes.
These collective results suggest that a high degree of posttran-
scriptional regulation is involved in the response of mammalian
cells to EGF.
Beyond general correlations, our results also suggest that some
functional classes of proteins show a greater tendency toward tight
coupling to transcriptional control than others. Most studies
reporting global measurements of gene and protein expression
levels have used single time point designs and rely on steady-state
Figure 6. Example network inferred from the integrated
datasets. Shown is the overall structure of one of the largest network
clusters identified from the combined microarray, LC-FTICR and
Powerblot datasets from the 0–4 hr early time domain. A) The source
of the data contributing to each element (node) in this network cluster
is coded by color, and connections between elements (edges) were
inferred from the literature using the MetaCore database. B) The cellular
processes represented by each node in the network are coded by color,
using the process categories from Figure 5.
doi:10.1371/journal.pone.0034515.g006
Table 2. Summary of network statistics derived from individual and integrated datasets.
Microarray alone LC-FTICR alone Microarray+LC-FTICR Microarray+LC-FTICR+PowerBlot
Total number of nodes 311 185 476 494
Size of largest cluster 50 19 142 169
% of nodes in largest
cluster
16 10 30 34
Number of edges 156 53 432 575
Degree of largest cluster 3.12 2.79 3.04 3.40
Two Primary hub nodes
(# of edges)
FOS (15) EGR1 (10) EGFR (7) ITGB1 (7) FOS (18) EGFR (16) FOS (28) SRC (25)
doi:10.1371/journal.pone.0034515.t002
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degradation processes that underlie changes in abundance (for
review see Waters et al, 2006). However, rates of protein
degradation and turnover can vary by orders of magnitude, even
with highly abundant proteins [36]. It was previously proposed
that for cell structural proteins there is a greater correlation
between protein and RNA expression changes than was predicted
from overall RNA/protein expression profiles [33,34]. Our
analyses focused on a subset of 199 RNA/protein pairs where
complete time course data was obtained, to avoid compounding
errors associated with extrapolation across missing data. This
subset of data is expected to be generally enriched with higher
abundance proteins. Proteins whose GO annotation included cell
structure and cell adhesion (52 total) were indeed the most highly
represented in this group, and included proteins such as tubulin
and actin subunits, and moesin. Still, when the frequency of
detection (i.e., spectra counts) was used as a means for normalizing
for abundance, we found no statistically significant trend toward
either concordant or discordant patterns of RNA and protein
temporal changes for these functional classes of molecules. In
contrast, RNA/protein pairs that showed more concordant
temporal profiles were statistically enriched with proteins involved
in protein synthesis and processing. Furthermore, RNA/protein
pairs that showed anti-correlated expression patterns were also
observed, and included a greater fraction of proteins involved in
primary metabolic processes associated with fatty acid and energy
metabolism than expected by chance. As a functional class,
primary metabolism proteins were not disproportionably repre-
sented in the subset of RNA/protein pairs evaluated (22 total).
Thus, these results are not readily explained by ‘sampling
frequency’ or by a general increase in mass spectrometry
measurement accuracy for abundant proteins. Admittedly,
inaccuracies and generalizations of GO annotation terms limit
their use for defining functional classifications. Nonetheless, the
results support the hypothesis that specific cell processes may
differentially utilize transcriptional and post-transcriptional mech-
anisms of control.
The major cell processes found to be modulated by EGFR were
qualitatively very different with respect to each measurement
platform (Fig. 5A). The emphases on different cell processes by
each platform are in part attributed to different depths of coverage
across the genome or proteome. As expected, microarray analysis
identified over 3- and 15-fold greater numbers of gene products
that changed compared to MS or Western blot analysis,
respectively. While some cell processes, such as cell adhesion
and cell motility, were similarly represented in all datasets, other
processes were preferentially represented by a specific dataset. For
example, less abundant and transiently induced proteins typical of
cell cycle regulation were not readily identified by either LC-
FTICR or antibody-based analysis, whereas microarray analysis
identified a large number of gene products associated with this
process. A strong bias toward signal transduction processes was
also highly apparent in the Western blot data (Fig. 5A), reflecting a
more general bias of commercially produced antibodies toward
signal transduction proteins. Despite the biases introduced by
individual datasets, the composite pathway analysis results
included most of the expected cell processes induced by EGFR
in this model system. For example, the combined results (Fig. 5B)
illustrate that following EGFR stimulation there is a general shift
in the major cell processes from cytoskeletal organization and cell
cycle regulatory processes during initial times (0–4 hr) toward anti-
apoptotic and cell adhesion pathways (8–13 hr). The temporal
evolution of these processes is consistent with the initial entry of
cells into S-phase, which begins at ,13 hr. Similarly, the
increased representation of mitosis pathways between 18–24 hr
corresponded to an increase in mitotic cells as monitored by flow
cytometry.
An important advantage of data integration observed here is
that the networks derived from heterogeneous datasets show a
more connected topology than networks derived from a single
dataset. Cellular signaling networks are thought to approximate a
scale-free topology, characterized by fewer nodes with a higher
degree of connectivity [37]. In this respect, networks inferred from
microarray data alone have the advantage of greater genomic
coverage compared to data from even the most advanced
proteomic platforms. Although networks derived from LC-FTICR
or antibody data alone had fewer nodes and less connectivity,
these datasets contributed important qualitative features to the
overall network structure, mostly because of their ability to
indicate the activity state of different signaling networks. Network
analysis of the integrated data revealed SRC and STAT3 as
among the most linked signaling nodes, consistent with previous
studies in HMEC [10]. It is noteworthy that these signaling nodes
were determined primarily from a subset of the Western blot
results that used phospho-specific antibodies. Despite the limited
overall amount of protein phosphorylation data, the topology of
the signaling networks derived from the integrated results was
highly dependent on these data. Other recent studies have also
reported novel findings through the incorporation of phosphory-
lation data into their analysis of disease and signaling networks
[38,39]. Given that dynamic modification of cellular proteins with
phosphate is one of the key regulators of cellular response, it is not
surprising that signaling network reconstruction is highly depen-
dent upon the collection of these data.
In contrast to the microarray results, 60% of the node-edge
relationships identified from the LC-FTICR data infer direct
protein interactions as regulatory mechanisms. The bias of LC-
FTICR results towards protein interactions is further implied from
network statistics showing that there were nearly 3-fold more
nodes with multiple edges (multiple effectors) than nodes with
single edges (binary interactions). This also contrasts the micro-
array data, where the fraction of inferred nodes with multiple
edges was only 1.6-fold greater than nodes with single edges. It is
noteworthy that based on microarray data alone, EGFR would
not have been identified as a major node in the pathway analysis.
However, the largest network clusters identified from the LC-
FTICR data alone included EGFR itself and b1-integrin as the
most connected nodes. Previous studies have reported that EGFR
and b1-integrin associate as a complex, providing a mechanism for
bidirectional coupling of EGFR signaling to the extracellular
matrix and other receptor pathways [40,41]. Activation of EGFR
by integrin complexes is thought to require SRC as a signaling
intermediate [40,41], consistent with our integrated network
analysis, which implicates SRC as a central node in the HMEC
EGFR network. We also found that the most robust responses
associated with EGF-induced mitogenesis were not classical cell
cycle regulators, but metalloproteases capable of remodeling the
local extracellular environment. This is in contrast to previous
microarray-based studies examining EGF responses of trans-
formed cells that found that induction of negative feedback
inhibitors of EGFR was a dominant response [42]. However,
unlike HMEC, cells in that previous study do not respond
mitogenically to EGF. The strong coupling of MMP cascades to
the mitogenic response observed in our study may be particularly
important for understanding the relationships between amplified
EGFR signaling and invasiveness of many epithelial cancers.
A limitation of pathway analysis using computational tools
based on literature-curated databases is that relationships
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such tools are highly useful for weighting abundance changes for
specific gene products identified experimentally and inferring
signaling linkages that are not always intuitive. By using curated
databases for comparison, our study illustrates some of the
strengths and biases inherent in different measurement platforms.
Despite platform-specific strengths and weaknesses, integration of
heterogeneous datasets not only enhances the connectivity of the
derived networks, but also qualitatively influences the regulatory
relationships inferred from high-dimensional data. Computational
inference of signaling networks would be a preferable strategy to
utilize all of the data, however inference utilizing multiple data
types is challenging due to differences in quantitative range and
sheer volume of data required for robust calculations
[19,43,44,45]. Despite the limitations of our study, the results
underscore the importance of data integration across multiple
molecular levels for reconstructing signaling networks that describe
cellular behavior. Future studies will focus on the use of dynamical
data (multiple time points and conditions) and computational
inference of disease networks from integrated data.
Materials and Methods
Materials and Cell Treatment
The human mammary epithelial cell line HMEC (strain
184A1), obtained from Martha Stampfer (Lawrence Berkeley
National Laboratory), [46] was used in this study. These cells are
non-tumorigenic and are dependent on EGFR signaling for
normal proliferation and motility in culture [20,21,22]. Cells were
routinely cultured in DHFB-I medium supplemented with
12.5 ng/ml EGF as described [20]. All other reagents were of
cell culture grade or higher quality.
For the experiments shown, 7.5610
4 cells were seeded in 150-
mm dishes and allowed 24 hr in complete medium for attachment
and growth. Growth arrest was induced by replacing the medium
with medium lacking serum, EGF and other growth factors for
48 hr. A mitogenic response was then initiated by treating cells
with 10 ng/ml EGF in minimal medium. Samples were collected
at 0, 0.25, 1, 4, 8, 13, 18 and 24 hr and processed for RNA
expression profiling and proteomic analyses as described below.
The fraction of cells in G0/G1, S and G2/M phases of the cell
cycle was measured in parallel samples by flow cytometry analysis
(Becton Dickinson FACSCalibur) after fixation in cold 70%
ethanol and labeling with propidium iodide.
Microarray Analysis
Total RNA was prepared using a Qiagen RNeasy Mini kit
(Qiagen, Valencia, CA, USA) and the integrity and purity
evaluated by gel electrophoresis and absorption spectroscopy.
RNA expression profiles were analyzed using NimbleGen whole
genome 60-mer oligonucleotide arrays (Design Version
2003_10_27) which contains 38,108 array elements (NimbleGen,
Madison, WI). Briefly, 0.5 mg of total RNA for each sample was
used for cRNA synthesis using oligo-dT primers and T7 RNA
polymerase through the NimbleGen Microarray Service facility.
Each biological sample was hybridized against 3 independent
arrays (3 technical replicates), and quality control assessment
determined that the arrays for the 15 minute time point failed to
hybridize according to manufacturer specifications. Raw intensity
data for the remaining arrays were quantile normalized [47] and
subjected to pairwise analysis of variance with a 5% false discovery
rate calculation [48] to identify significantly changed genes.
Western Blot Analyses
For analysis of protein abundance changes, cell pellets collected
at different time points were separately washed three times with
ice-cold phosphate-buffered saline. The cells were lysed in buffer
(10 mM Tris, 150 mM NaCl, 1% NP-40, 1 mM NaVO3,1 0m M
NaF, and protease inhibitor cocktail, pH 7.4) using intermittent
sonication on ice. The lysates were centrifuged for 20 min at 4uC
at 14000 g to pellet any residual debris. Protein concentrations
were determined using the BCA assay (Pierce Biochemical).
Parallel Western blot analyses were performed by BD Biosciences
(San Diego, CA) through their PowerBlot
TM custom service using
the complete array of available antibodies (1011 total). This
approach employs co-hybridization of panels of antibodies that
recognize distinctly migrating proteins on denaturing gradient
gels, followed by detection with secondary antibody and
quantification by gel image analysis. Samples were analyzed in
triplicate, and gel image analysis of expression ratios were
determined using a 363 matrix comparison method to determine
the ratio of treated:control (0 hr) for each of the triplicate analyses.
Only proteins which passed visual inspection of the image quality
and showed a $1.5-fold change compared to control (0 hr) were
considered significant. The raw microarray data files are publicly
available in GEO (GSE15668), and significant gene lists used in
the bioinformatics analyses are included as Table S1 with this
manuscript.
Mass spectrometry-based proteomic analysis
For MS-based proteome analysis, we used the accurate mass
and time (AMT) tag approach [23]. The approach uses the high
mass measurement accuracy of Fourier-transform ion cyclotron
resonance-mass spectrometry (FTICR-MS), coupled with ad-
vanced capillary liquid chromatography (LC) separations to
identify and estimate the abundance of peptides. An existing
AMT tag database encompassing the monoisotopic mass and
normalized chromatographic elution times of peptides identified
from previous LC-MS/MS analyses of HMEC proteins under a
range of experimental conditions [9,24,25,26] was used as a base
reference database for the LC-FTICR measurements in this study.
The existing HMEC database was further enriched by conducting
additional LC-MS/MS analysis using 375 mg of HMEC protein
pooled from each of time point samples in this study. Details of
LC-MS/MS analysis and data filtering involved in peptide
identification have been described elsewhere [26]. Peptide
identifications in this database were obtained using the SEQUEST
algorithm to independently search all MS/MS spectra against the
human International Protein Index (IPI) database and against the
reversed-sequence human IPI protein database to estimate the
false discovery rate. Criteria that would yield an overall confidence
of over 99% were established for filtering raw peptide identifica-
tions at spectra level. The peptide retention times from each LC-
MS/MS analysis were normalized to a range of 0–1 using a
predictive peptide LC-normalized elution time (NET) model and
linear regression as previously reported [49].
For quantitative analysis by LC-FTICR, proteins from each of
the eight lysates were digested with trypsin separately and cysteinyl
and non-cysteinyl peptides was prepared from the tryptic digests
and were differentially labeled separately using post-digestion
trypsin-catalyzed
16O-to-
18O exchange as previously described
[9]. The control sample (0 hr) was labeled with
16O and all the
other samples (t=0.25, 1, 4, 8, 13, 18 and 24 hr) were labeled with
18O. Supernatants were collected by centrifuging the samples for
5 min at 15000 g, and equal amounts of the
16O-labeled control
sample were combined with each of the
18O-labeled time point
samples, and dried.
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mass spectrometer. The same LC system and gradient was
applied for LC-MS/MS and LC-FTICR analysis. The LC-
FTICR data analysis was conducted as previously described
[50]. Briefly, the initial analysis of raw LC-FTICR data
involved a mass transformation or deisotoping step using in-
house software (ICR2LS). The ICR2LS analysis generates a
text file report for each LC-FTICR dataset that includes the
monoisotopic masses and the corresponding intensities for all
detected species for each spectrum. In-house software (VIPER)
was used to detect LC-MS features (i.e., a peak with unique
mass and elution times) and assign them to peptides in the
AMT database. Data processing steps included filtering data
based on isotopic fitting, finding features and pairs of features,
computing abundance ratios for pairs of features (
16O:
18O),
normalizing LC elution times, and matching the accurate
measured masses (65 ppm) and NET (62%) values of each
feature to the corresponding mass and time tag in the database
to identify peptide sequences. All identified peptides were
assigned an identical probability of 1.0 and entered into
ProteinProphet software [51] to remove redundant proteins.
Protein abundance ratios were calculated as an average of the
isotopic ratios of both the cysteinyl and non-cysteinyl peptides
after removing outliers using Grubb’s test. For final network
and pathway analysis, only proteins identified by at least two
peptides and those that showed a $1.5-fold change compared
to control (0 hr) were used. The proteomic data generated in
this study are publicly available at http://omics.pnl.gov, and
final datasets used in the bioinformatics analyses are submitted
as Table S1 with this manuscript.
Bioinformatic and statistical analysis
Data were integrated across platforms using the Bioinformatics
Resource Manager software [52]. Hierarchical and Kmeans
cluster analyses of microarray and proteomic data were
performed using OmniViz (Maynard, MA) and Multi-Experi-
ment Viewer [53] software and were based on log10 expression
ratio values. Biological process enrichment statistics were
calculated using the pathway mapping tool, MetaCore (GeneGo,
St Joseph, MI) based upon a hypergeometric distribution where
the p-value represents the probability of particular mapping
arising by chance, given the number of significantly regulated
genes/proteins in the dataset, the total number of genes assigned
to a process, and the background genes/proteins experimentally
identified by the platform. Networks were reconstructed using
MetaCore’s direct interaction algorithm, where the only edges
allowed are those between two root nodes (e.g., objects from the
list directly connected to each other) using their proprietary
database of curated interactions from the literature. The resulting
integrated network was redrawn using Cytoscape [54] for
illustration.
Canonical correlation analyses of time profile microarray and
proteomic data were conducted using the freely available R
software (version 1.7.1; R Development Core Team, 2004). Prior
to analysis all time profiles were individually transformed to have
mean 0 and standard deviation 1, so that subsequent comparisons
emphasize the shapes of the profiles. Canonical correlation
analysis (using the cancor function in R) was used to assess the
overall (global) concordance of RNA and protein temporal
expression profiles. The significance of the observed canonical
correlations was evaluated by permuting protein labels (but
keeping time profiles intact), and computing the canonical
correlations for each of 1000 permutations. Genes were ranked
according to the concordance of their individual RNA and protein
expression profiles. Rankings were made by reference to a
smoothing model. Let YRNA
gt and YProt
gt denote the scaled log2
expression values at time t for gene g for RNA and protein,
respectively. The respective time profiles were fit to the models





where bg and lg are parameter vectors, estimated from the data,
describing the shapes of the corresponding RNA and protein time
profiles, and the regression vector x(t) is a spline basis function
with 3 degrees of freedom. Two criteria were used to rank genes.
The first is whether bg~lg, that is, that the two smoothed profiles
have identical shape. The second is the overall significance of the
regression (across both RNA and protein profiles) given that
bg~lg. Rankings were based on an F-test statistic reflecting the
tradeoff, or compromise, between the two criteria. We constructed
a (data-determined) composite measure as a scalar function of F1
and F2 to rank genes according to RNA-protein concordance.








Enrichment of protein functional groups was then assessed for
RNA and protein time profiles as a function of their concordance,
relating the F1 score of concordance to gene ontology category.
For each gene we computed two F1 scores: one for positive
concordance (given in Table 1) and one for negative concordance.
These scores are related separately to GO category and are both
given for the example gene/protein pairs in Figure S1. For positive
concordance within each process, the relationship between
concordance score F1 and category membership (0 or 1) was
assessed separately for each category using the Wilcoxon rank sum
test.
Supporting Information
Figure S1 Example RNA and protein expression profiles
showing correlated (A) and anti-correlated (B) temporal
patterns. The x-axis is time in hours. The left-hand y-axis is the
RNA scale, and the right-hand y-axis is the protein abundance
scale. The RNA profile is shown in red and protein profile is in
blue. The dashed line indicates the regression-based fit for
temporal concordance. Values are expressed as log2 expression
ratios.
(TIF)
Figure S2 EGFR-Regulated Secretion of Matrix Metal-
loproteases. HMEC were treated with EGF (10 ng/ml), alone
or in the presence of the selective EGFR kinase inhibitor
PD153035 (200 nm). MMP-1 and MMP-10 protein levels were
measured in conditioned medium at 24 hr using ELISA (R&D
Systems, Minneapolis, MN). Values are the mean 6 s.d. of
biological triplicates.
(TIF)
Table S1 Significant gene and protein lists measured by
microarrays, FTICR proteomics and western blot
analysis in the time course study. The file includes gene/
protein identifiers from each platform and values listed are log10
expression ratios relative to time 0 hr controls.
(XLS)
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